24 April 2019; Company Announcement – Duke Health Final – Acrobat pdf 121k

Highlights

  • PME signs 7-year deal with Duke Health
  • Duke ranked in the top 20 best hospitals in the U.S.
  • Visage 7 to be implemented across all of Duke’s radiology departments
  • Transaction-based model with potential upside
  • Adds to PME’s growing footprint in the tier 1 U.S. academic hospital segment

Leading health imaging company Pro Medicus Limited

[ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year contract with Duke Health (“Duke”), the largest health system in the state of North Carolina and one of the most respected health providers in North America.

The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented across all of Duke’s radiology departments and integrated to Duke’s electronic health record (EHR).

The implementation will span three hospitals and dozens of additional locations across Duke Health, including their flagship 957-bed academic medical center, Duke University Hospital. Planning for the rollout is to commence in Q4 FY19 with the first sites scheduled to be implemented in Q1 FY20.

“This is another significant deal for us,” said Dr Sam Hupert, Pro Medicus CEO. “Duke is a leading U.S. academic institution and adds to the growing number of top-ranked North American health systems standardising on our technology. This not only helps consolidate our strong position in this highly competitive market, it enables us to leverage our development and commercialisation efforts across an increasing base of academic, research oriented clients which we feel provides us with a strategic advantage particularly in rapidly evolving fields such as artificial intelligence and machine learning.”